Abeona Therapeutics Inc.

DB:PCJ Stock Report

Market Cap: €250.3m

Abeona Therapeutics Management

Management criteria checks 2/4

Abeona Therapeutics' CEO is Vish Seshadri, appointed in Oct 2021, has a tenure of 3.08 years. total yearly compensation is $2.85M, comprised of 19.5% salary and 80.5% bonuses, including company stock and options. directly owns 2.07% of the company’s shares, worth €5.19M. The average tenure of the management team and the board of directors is 3.1 years and 3.7 years respectively.

Key information

Vish Seshadri

Chief executive officer

US$2.8m

Total compensation

CEO salary percentage19.5%
CEO tenure3.1yrs
CEO ownership2.1%
Management average tenure3.1yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Vish Seshadri's remuneration changed compared to Abeona Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$71m

Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$77m

Dec 31 2023US$3mUS$555k

-US$54m

Sep 30 2023n/an/a

-US$45m

Jun 30 2023n/an/a

-US$39m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$1mUS$505k

-US$43m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$84m

Mar 31 2022n/an/a

-US$91m

Dec 31 2021US$2mUS$255k

-US$85m

Compensation vs Market: Vish's total compensation ($USD2.85M) is above average for companies of similar size in the German market ($USD782.05K).

Compensation vs Earnings: Vish's compensation has increased whilst the company is unprofitable.

CEO

Vish Seshadri (48 yo)

3.1yrs

Tenure

US$2,847,442

Compensation

Dr. Vishwas Seshadri, also known as Vish, Ph.D. & M.B.A., serves as Chief Executive Officer, President and Director at Abeona Therapeutics Inc. since October 15, 2021. He served as the Senior Vice Presiden...

Leadership Team

NamePositionTenureCompensationOwnership
Vishwas Seshadri
President3.1yrsUS$2.85m2.07%
€ 5.2m
Joseph Vazzano
Chief Financial Officer2.7yrsUS$1.49m0.84%
€ 2.1m
Brendan O'Malley
Senior VP & General Counsel4.6yrsUS$1.17m0.63%
€ 1.6m
Brian Kevany
Senior VP3.4yrsno datano data
Gregory Gin
Vice President of Investor Relations & Corporate Communicationsno datano datano data
Alison Hardgrove
Chief People Officer2.8yrsno datano data
Jon Voss
VP & Head of Quality3.1yrsno datano data
Madhav Vasanthavada
Senior VP1.2yrsno datano data
Carl Denny
Senior Vice President of Regulatory Affairsno datano datano data

3.1yrs

Average Tenure

51.5yo

Average Age

Experienced Management: PCJ's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Vishwas Seshadri
President3.1yrsUS$2.85m2.07%
€ 5.2m
Mark Alvino
Independent Director3.7yrsUS$336.14k0.17%
€ 415.4k
Faith Charles
Independent Director3.7yrsUS$336.14k0.26%
€ 653.1k
Donald Wuchterl
Independent Director3.6yrsUS$330.52k0.26%
€ 657.6k
Eric Crombez
Independent Directorless than a yearno data0.025%
€ 63.4k
Christine Berni-Silverstein
Independent Director4.7yrsUS$324.89k0.22%
€ 559.7k
Leila Alland
Independent Director3.6yrsUS$336.14k0.27%
€ 679.1k
Steven Gray
Member of Scientific Advisory Board7.6yrsno datano data
Erika Augustine
Member of Scientific Advisory Board7.6yrsno datano data
Jonathon Mink
Member of Scientific Advisory Board7.6yrsno datano data
John Cooper
Member of Scientific Advisory Board7.6yrsno datano data
Michael Amoroso
Chairman of the Board3.7yrsUS$351.14k0.33%
€ 829.0k

3.7yrs

Average Tenure

51yo

Average Age

Experienced Board: PCJ's board of directors are considered experienced (3.7 years average tenure).